Regulatory support for the development of a stem cell therapy and device for the treatment of Parkinson’s Disease

Boyds provided regulatory support to an academic institution client with an exciting proposal for a first-in-human stem cell therapy trial involving a medical device for the treatment of Parkinson’s Disease.